We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Merck executives praised the U.S. government for tax reform on Friday, but the drugmaker is projecting a flat tax rate this year as many of its peers expect a benefit.